Robert H.
Keller, MD, MS, FACP, AAHIVS Curriculm Vitae
Robert H. Keller MD, MS, FACP,
has been named as one of the world's 2,000 Outstanding Scientists of the
21st Century, and has served on the scientific review panels for the
National Institutes of Health and the VA.
The Consumers Research
Council has named Dr. Keller one of America's Top Physicians in 2003,
2004, 2005, 2006, and 2007 in the fields of Internal Medicine,
Immunology and Hematology. Dr. Keller has served on the faculties of
the Mayo Graduate School of Medicine, the University of Wisconsin and
the Medical College of Wisconsin (Marquette Univ.) He has published more
than 100 original articles in various scientific and medical journals
and has been awarded several patents. Dr. Keller was elected to
The Board of Governors of the American Academy of HIV Medicine.
*MaxGxl
Testimonies
Bachelor of Arts in Biology Master
of Science in Biology Fordham University, Bronx, New York
1966
Bachelor of Arts in Biology Master
of Science in Biology Fordham University, Bronx, New York
1970
Doctor of Medicine (MD) with honors
Temple University, Philadelphia, Pennsylvania
1970-1974
Internship, Resident and Senior
Resident University of Rochester, Rochester, New York
1974-1976
Fellow and Senior Fellow Department
of Immunology Mayo Clinic, Rochester, Minnesota
1976
Master of Science in Immunology Mayo
Graduate School of Medicine Rochester, Minnesota
Professional and
Faculty Positions:
2006
Founder, CSO and Director of
Medicine KBK Institute of Advanced Medicine Hollywood, Florida
2001
Founder, Chairman, CEO & CSO Phoenix
BioSciences which has developed a new first in class and first in
man viral-host interaction inhibitor for HIV / AIDS
1999
Founder, Chairmain,CEO and CSO
Vitimmune, Inc Hollywood, Florida
1998
Voluntary Adjunct Professor Miller
School of Medicine, University of Miami Miami, Florida
1996
Chairman and CEO Immune Balance
Technologies Hollywood, Florida
1994-2006
Director of Medicine & Research
BIODORON Medical Center Hollywood, Florida
1994-1995
Consultant in Immunology and
Hematology Health Professionals, Inc and Center for Special
Immunology
1992-1995
Director Immune Reconstitution
Program Center for Special Immunology
1992-1995
Medical Director Center for Special
Immunology Miami Beach, Florida
1987-1996
President and Medical Director The
Wilson Bode Center Fort Lauderdale, Florida
1986-1987
Associate Director of Research and
Development Coulter Immunology Coulter Electronics, Inc., Hialeah,
Florida
1982-1986
Medical Director Wilson Bode Center
for Hematology and Immunology Research Milwaukee, Wisconsin
1982-1986
Clinical Professor Department of
Health Sciences (Hematology, Immunology, Flow Cytometry)
University of Wisconsin Milwaukee, Wisconsin
1982-1986
Associate Professor Departments of
Medicine and Biophysics Medical College of Wisconsin Milwaukee,
Wisconsin
1982-1986
Clinical Investigator and Staff
Physician Zablocki VAMC Milwaukee, Wisconsin
1980-1982
Director of Immunology Midwest
Children's Cancer Center (Immunology, Flow Cytometry,
Transplantation) Chief of Immunology Milwaukee Children's Hospital
Milwaukee, Wisconsin
1980-1982
Associate Professor Department of
Pediatrics (Hematology/Oncology, Immunology) Medical College of
Wisconsin Milwaukee, Wisconsin
1979-1982
Clinical Associate Professor
Department of Health Sciences (Hematology, Immunology, Flow
Cytometry) University of Wisconsin Milwaukee, Wisconsin
1978-1980
Research Associate and Staff
Physician Research Service Zablocki VAMC Milwaukee, Wisconsin
1977-1980
Assistant Professor Department of
Medicine (Hematology/Oncology) Medical College of Wisconsin
Milwaukee, Wisconsin
1977
Consultant And Assistant Professor
Department of Immunology Mayo Medical School Dept. of Medicine
University of Minnesota
1974-1977
Fellow and Senior Research Fellow in
Immunology Mayo Clinic Foundation Mayo Graduate School of Medicine
Rochester, Minnesota
Hospital Staff
Appointments:
1976-1977
Mayo Clinic, Rochester, Minnesota
1977-1986
Zablocki VAMC, Milwaukee, Wisconsin
1977-1986
Milwaukee County Medical Complex,
Milwaukee, Wisconsin
1992-1997
Mount Sinai Medical Center, Miami
Beach, Florida
1992-1999
Cleveland Clinic Hospital, Fort
Lauderdale, Florida
1992-1999
Miami Heart Institute, Miami Beach,
Florida
1997-1999
Palmetto General Hospital, Hialeah,
Florida
1997- 2005
South Shore Hospital, Miami Beach,
Florida
1997- 2005
Memorial Medical Center, Hollywood,
Florida
1992-
Broward General Medical Center, Fort
Lauderdale, Florida
National Board of
Medical Examiners, 1971 and 1990
American Board of
Internal Medicine, 1974
American Academy of HIV
Medicine, 2001
American Academy of Anti
Aging Medicine 2006
Current Medical
Licensure:
New York
#112195
Wisconsin
#19121
Florida
#58991
Certification:
ACLS
1990
ATLS
1990
Professional Societies:
Alpha Omega Alpha
American Association for
the Advancement of Science
American Association of
Immunologists
American College of
Physicians
American Federation of
Clinical Research
American Society of
Clinical Pathology
American Society of
Hematology
International Society of
Hematology
International Society of
Hematopathology
International
Immunocompromised Host Society
International Society of
Analytical Cytology
Clinical Cytometry
Society
New York Academy of
Sciences
Clinical Immunology
Society
National Organization
for Rare Disorders
American Academy of Anti
Aginig Medicine
Teaching Experience:
1978-1980
Survey in Basic and Clinical
Immunology Department of Medicine Medical College of Wisconsin
1980-1983
Principles of Laser Flow Cytometry
Department of Health Sciences University of Wisconsin
1981
Special Topics in Immunology
Immunoregulation in Cancer Department of Biology Marquette
University
1983-1986
Co-Director Flow Cytometry Program
University of Wisconsin Introduction to Flow Cytometric Analysis
Principles of Image and Laser Cytometry Hybridomas and Monoclonal
Antibodies Laboratory Evaluation of Immunoregulation Clinical
Immunophenotyping and DNA Analysis Advanced Cytometry Advanced
Cytometric Techniques
Invited Professional
Lectures:
1979 - Dr. Keller has
been the invited speaker at more than 2500 state, regional,
National, and international, medical and scientific seminars and
workshops In the fields of:
AIDS and Immunoregulation
Clinical Immunology
Chronic Fatigue Syndrome and Fibromyalgia
Autoimmune Disease and Control of Aberrant Immune Response
Nutrition and the Immune Response
Hormones and the Immune Response
Hepatitis C
Hemophilia
Protecting the Immune System Before, During, and After Cancer
Therapy.
Age Management
2000-2002
Host of Today's Health, WAXY 790 and
Web streamed at Vitimmune.com and RobKellermd.org
2005-2006
Host of Voice America Web Based
Interactive Radio Show, The Path to Wellness and Youth
Committee Service:
1985-1986
Veterans Administration Development
Research and Committee Clement J. Zablocki
VAMC
1986-1989
VA Oncology Merit Review Board
1984-1986
International Society For Analytical
Cytology: Research and Development
1983-1986
Controls & Standards University of
Wisconsin: Co Chair Flow Cytometry
1983-1986
National Institutes of Health:
Special Immunology Review Council Study Section
1980-1982
Medical College of Wisconsin Faculty
Welfare Committee
1980-1982
Animal Care Committee
1982-1986
Flow Cytometry Protocol Committee
1992
Cancer Committee for Hollywood
Medical Center
1998
Committee of Ten Thousand Medical
Advisory Board
1996
National Hemophilia Federation:
Medical Advisory Committee
1994
National Hemophilia Foundation-
Florida Chapter Medical Advisory Committee
1994-1997
Mount Sinal Medical Center Cancer
Committee
2001
Hollywood Medical Center Cancer
Committee
2005
Underwriting Committee ProAssurance
Malpractice
2005
AAHIVM Standards of Practice
Committee
Statement of Research
Interest:
HIV: Dissection of the
immune perturbations Associated with HIV infection including
therapy with experimental immunomodulary agents.
Dissection of the immune
perturbations Associated with hemophiliac complication and
therapeutic intervention using experimental immunoregulatory
agents.
Creation and utilization
of unique `designer` monoclonal antibodies for the diagnosis,
monitoring, imaging and therapy of human hematologic and solid
tumor malignancies.
Immune response and
immunoregulation: dissection of the basic human immune response
and the roles of cytokines and other regulatory molecules and the
demonstration and characterization of aberrant responses in
neoplastic and immunologic disease.
Nutritional/ Hormonal
Supplementation in Age Management and Immunologic Disease
Patents Issued:
R.H. Keller and Dr. X.
Wen: Allerg-ease (Patent Number 6,180,106) (2000)
R.H. Keller, D.W.
Kirchenbaum: ALL-Immune (Patent Number 6,262,019) (2002)
R.H. Keller, PBS 119 a
novel treatment for chronic viral infections (Patent Number
6,734,192) (2004)
Keller, R.H. and Tomasi,
T.B.: Alpha-fetoprotein: A Potential Regulator of Immune Function.
In Diseases of the Liver and Biliary Tract. Javitts, N.NIH,
Bethesda, Maryland, pp. 119-134, 1977.
Keller, R.H., Calvinico,
N.J., Fink, J.N., and Stevens, J.O.: Immunobiologic Aspects of
Primate Hypersensitivity Pneumonitis. In Environmental Toxicology.
Dungworth, D.L. (Ed), Academic Press, New York, pp.383-395, 1981.
Keller, R.H., Blake, D.G.,
Lyman, S. and Siebenlist, R.: The Immunobiology of Human
Non-Hodgkin's' Lymphomas. In Clinical Cellular Immunology. Ludered,
A. (ed). Humana Press, New York, pp. 213-246, 1982.
Patrick, C.W., Keller,
R.H., and Horan, P.K.: Flow Cytometry, Cell Sorting and Hybridomas.
American Society Clinical Pathology Press. St. Louis, MO, pp.
1-182, 1982.
Patrick, C.W., Parker,
J., Keller, R.H., and Horan, P.K.: The Clinical Utility of
Monoclonal Antibodies and Immunophenotyping. In Flow Cytometry and
Cell Sorting in Hematologic Disease. American Society of American
Pathologists Press. Chicago, IL pp. 1-191.
Calvinico, N.J., Fink,
J.N., and Keller, R.H.: Hypersensitivity Pneumonitis. In The
Immunology of the Lung. Bienenstock, J. (Ed), Academic Press, New
York pp 365-366, 1984
Keller, R.H., Milson,
T.J., Janicek, K.M., Patrick, L.C., Sohnle, P., and Patrick, C.W.:
Clinical Utilization of the Technicon H-6000 Flow Cytochemical
Flow System in Allergy Testing. In Proceedings of the 4th
International Technicon Hematology Colloquium. Simson, E. (ed)
Academic Press, New York, pp 179- 188, 1984.
Patrick, C.W., Horan,
P.K, and Keller, R.H.: Immunophenotypic and Functional Analysis
Using Laser Flow Cytometry: Clinical Utility. American Society of
Clinical Pathology Press, Chicago, IL, 1985, pp. 1-168.
Patrick, C.W. and
Keller, R.H.: Lymphocytes: Biochemistry, Physiology, Function and
Morphology. In Principles of Hematology: Clinical and Laboratory
Practice. R.L. Bick, (Ed) C.V. Mosby, St. Louis, MO in press.
Patrick, C.W. and
Keller, R.H.: The Emerging Role of Laser Flow Cytometry and
Monoclonal Antibodies in Clinical Medicine. In: Principles of
Hematology: Clinical Laboratory Practice. R.L. Bick (Ed) C.V.
Mosby, St. Louis, MO, in press.
Keller, R.H. and
Patrick, C.W.: Characterization of the Human Myeloid Series by
Monoclonal Antibodies. In Monoclonal Antibodies in Laboratory
Medicine. Swartz, M. (Ed) Academic Press, New York, in press.
Patrick, C.W., McFadden,
P.W., and Keller, R.H.: Immunophenotypic Analysis of Human Bone
Marrow Employing Monoclonal Antibodies and Laser Flow Cytometry.
In Proceedings of the Second International Conference on
Technological Advances in Laboratory Hematology. Howen, B. (ed),Academic
Press, 1985.
Keller, R.H., Janicek,
K.M., and Patrick, C.W.: The Clinical Significance of Laser Flow
Cytometry DNA Analysis. In Proceedings of the Second International
Conference on Technological Advances in Laboratory Hematology.
Howen, B. (Ed) Academic Press, New York, 1985.
Keller, R.H., Van Riel,
F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G, Fletcher,
M.A.: Association of Histocompatability Class II Antigens wit the
Chronic Fatigue Immune Dysfunction Syndrome. In Clinical
Infectious Disease. University of Chicago, Chicago, IL, 1994:18
(Supp 1): S154-6.
Antioxidants and the
skin, A Paradigm for aging. Keller, R.H and E Arrayove (in press)
2004. glutathione in Aging and Immunologic Disease. Loss of
Gastrointestinal During Aging and Immunologic Disease Both Ed R.
Wallace and Mechanisms of Aging Dove Press N Z, 2006
Original Research
Contributions and Invited Reviews: Keller, R.H. and Tomasi, T.B.:
Alpha-fetoprotein, E-Rosette Formation and Tumor Cell Growth. N
Engl J Med 293(24): 1265-1266, 1975.
Tomasi, T.B., Dattwyler,
R., Murgita, R. and Keller, R.H.: Immunosuppression By
Alpha-fetoprotein. Trans Am Assoc Phys. 88:293-298, 1976.
Geubel, A.P., Keller,
R.H., Summerkill, W.H.J., Dickson, E.R., Tomasi, T.B. and Shorter,
R.G.: Lymphocyte Cytotoxicity and Inhibition Studied with
Autologous Liver Cells: Observation in Chronic Acute Liver Disease
and the Primary Biliary Cirrhosis Syndrome. Gasterenterol.
71:450-459, 1976.
Keller, R.H. and
Clavanico, N.J., and Tomasi, T.B.: Immunosuppressive Properties of
AFP: Role of Estrogens. In Onco Developmental Gene Expression.
Fichman, W.H. and Sell, S. (eds) Academic Press, New York, p.278,
1976.
Keller, R.H. and Tomasi,
T.B.: Synthesis of Alpha-fetoprotein by Murine Lymphoid Cells in
Allogenic Reactions. J Exp Med 143:1120, 1976.
Banks, P., Keller, R.H.,
Li, V.Y. and White, E.B.: Malignant Lymphomas of Plasmablastic
Identity: A Neoplasm with Both "Immunoblastic" and Plasma Cell
Features. Am J Med 64:609-610, 1978.
Keller, R.H., Atwater,
J.S., Martin, R.S. and Tomasi, T.B.: Ataxia Telangiectasia,
Immunosuppression and AFP: Is There a Relationship? In Prevention
of Neural- Tube Defects. Crandall, B. (ed) Academic Press, New
York, pp.27-40, 1978.
Guirgis, H.A., Lynch,
H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J., Brodky, F.,
Lynch, J., Rankin, L. and Malony, K.: Carcinoembryonic Antigen (CEA)
and Alpha-fetoprotein (AFP) in Cancer-Prone Families: Communicable
Implications. In Proceeding of the Third Annual Symposium on the
Detection and Prevention of Cancer. Part I (2), 1987.
Keller, R.H., Dattwyler,
R.J., Harrison, E. and Tomasi, T.B.: Alpha-fetoprotein in Human
Lymphoproliferative Disease. J Lab Clin Immunol, 2:93-98, 1979.
Kaplan, H.J., Meredith,
T.A., Aeberg, T.M. and Keller, R.H.: Intraocular Reticulum Cell
Sarcoma (Histiocytic Lymphoma) in Richter's Syndrome: A Neoplasm
of the Immune System. Arch Opthal 98:707-710, 1980.
Keller, R.H., Blake, B.G.,
Lyman, S. and Siebenlist, R.: ImmunoregulatoryAbnormalities in
Chronic Lymphocytic Leukemia. J Lab Clin Immunol 6:201-208, 1981.
Choi, H. and Keller, R.H.:
Co-existence of Chronic Lymphocytic Leukemia and Hodgkin's
Disease. Cancer 48:48-55, 1981.
Kaplan, H.J., Aeberg,
T.M. and Keller, R.H.: Etiology of Recurrent Clinical Uveitis. Ber
Dtsch Ophthal Ges 78:159, 1981.
Kaplan, H.J. and Keller,
R.H.: Recurrent Clinical Uveitis: Cell Surface Markers on Vitreous
Lymphocytes. Arch Ophthal 100:585-592, 1982
Keller, R.H., Fink, J.N.,
Lyman, S. and Pederson, G.: Suppressor Cells in Asymptomatic
Pigeon Breeders. J Clin Immunol 2:46-51, 1982.
Milson, T.J., Grief, D.
and Keller, R.H.: The Variable Effect of Cryopreservation on
Peripheral Blood Mononuclear Populations. J Clin Lab Immunol
7:205-218, 1982.
Keller, R.H., Calvanico,
N.J. and Stevens, J.O.: Hypersensitivity Pneumonitis In Non-human
Primates. In Studies on the Relationship of Immunoregulation and
Disease Activity. J Immunol 128:116-123, 1982.
Keller, R.H.:
Alpha-fetoprotein: Biologic and Clinical Potential. In Tumor
Imaging: The Radioimmunochemical Detection of Cancer. Burchiel, S.
and Rhodes, B. (eds) Mason Publishing, New York, pp. 179-188,
1982.
Patrick, C.W. and
Keller, R.H.: New Techniques in the Diagnosis of Hematopoietic
Malignancies: Monoclonal Antibodies, Flow Cytometry and Cell
Sorting. Am Soc Clin Pathol Sp Topic Series 20(3)106-109, 1982.
Keller, R.H., Libnoch,
J.A., Patrick, C.W., Blake, D.G., Choi, H. and Hanson, R.D.: Fc
Gamma Bearing T Cells in Non-Hodgkin's Lymphomas. Diag Immunol
1:27-32, 1983.
Keller, R.H., Feldman,
E. and Libnoch, J.A.: Immunoregulatory Abnormalities the Kindred
of Waldenstrum's Macroglobulinemia Patients. Am J Hematol
14:15-22, 1983.
Fudenberg, H.H., Wilson,
G.B., Keller, R.H., Metcalf, J.F., Pauling, E.E., Stuart, E.J. and
Floyd, E.: Clinical Application of the Leukocyte Migration
Inhibition Assay: New Methods for Determining Transfer Factor
Potency and for Prediction of Clinical Response. In Proceedings of
the IV International Conference on Transfer Factor. Academic
Press, New York, pp. 293-310, 1984.
Patrick, C.W. and
Keller, R.H.: A Simple Device for the Collection of Cells Sorted
by Flow Cytometry: Preservation of Integrity and Viability.
Cytometry 5(3):308-311, 1984.
Keller, R.H., Milson,
T.J., Janicek, K.M. and Patrick, C.W.: Monoclonal Antibodies:
Clinical Utility and the Misunderstood Epitope. Lab Med
15(12):785-802, 1984.
Keller, R.H., Swartz,
S.J., Leven, S., Bar Sella, S. and Fink, J.N.: Immunoregulation in
Hypersensitivity Pneumonitis: Phenotypic and Functional Studies of
Bronchoalveolar Lavage Lymphocytes. Am Rev Resp Dis 130:766- 771,
1984.
Patrick, C.W., Swartz,
S.J., Harrison, K.A. and Keller, R.H.: Collection and Preparation
of Hemopoietic Cells for Cell Marker Analysis. Lab Med 15(10):
659-665, 1984.
Patrick, C.W., Milson,
T.J., McFadden, P.W. and Keller, R.H.: Flow Cytometry and Cell
Sorting. Lab Med 15(11):740-745, 1984.
Wilson, G.B., Fudenberg,
H.H. and Keller, R.H.: Guidelines for Immunotherapy of Antigen
Specific Defects with Transfer Factor. J Clin Lab Immunol
13:51-58, 1984.
Baumann, M.A., Libnoch,
J.A., Patrick, C.W., Choi, H. and Keller, R.H.: Prolonged Survival
in Richter's Syndrome with Subsequent Re-emergence of Chronic
Lymphocytic Leukemia: A Case Report Including Serial Cell Surface
Phenotype Analysis. Am J Hematol 20:67-72, 1985.
Marti, G.E., Patrick,
C.W., Muirhead, K., Magruder, L., Vail, M., Schuette, W., Keller,
R.H., Horan, P.K. and Gralnick, H.R.: Normal Blood Density
Gradient Lymphocyte Subset Analysis: In an Inter-Laboratory Flow
Cytometric Comparison of 85 Normal Adults. Am J Hematol 20:41-52,
1985.
Milson, T.J., Patrick,
C.W., Torke, N.J. and Keller, R.H.: Holding Media for Cell Surface
Phenotyping Analysis, J Immunol Methods 87: 155-159, 186.
Baumann, M.A., Milson,
T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.:
Immunoregulatory Abnormalities in Myelodysplastic Disorders. Am K
Hematol 22:79-86, 1986
Hansen, R.M, Lerner, N.,
Abrams, R.A., Patrick, C.W., Malik, M.I. and Keller, R.H.: Chronic
Lymphocytic Leukemia with Pure Red Cell Aplasia: Laboratory
Demonstration of Persistent Leukemia in Spite of Apparent Complete
Clinical Remission. Am J Hematol 22:79-86, 1986.
Baumann, M.A., Keller,
McFadden, P.W., Libnoch, J.A and Patrick, C.W.: Myeloid Cell
Surface Phenotype in Myelodysplasia: Evidence for Abnormal
Persistence of an Early Myeloid Differentiation Antigen. Am J
Hematol 23:22-26, 1986.
Baumann, M.A., Milson,
T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Correlation
of Numbers of Natural Killer Cells with Clinical Course in Large
Cell Lymphoma. Cancer 57:2309-2312, 1986.
Patrick, C.W., Ash, R.,
Libnoch, J.A. and Keller, R.H.: Clinical Cytometry and
Immunophenotyping: I. Flow Cytometric Analysis of Normal
Peripheral Blood and Bone Marrow. Path Immunopathol Res 6:64-76,
1987.
Patrick, C.W., Libnoch,
J.A., Kallas, G.A. and Keller, R.H.: Sequential Immunophenotypic
Studies in Chronic Lymphocytic Leukemia: UCLA Molecular Biology
Symposium. Chronic Lymphocytic Leukemia: Recent Progress-Future
Directions. R. Gale and K. Rai (eds) Alan R. Liss, New York, 59,
1987.
Keller, R.H., Libnoch,
J.A., Kallas, G.A., and Patrick, C.W.: Sequential Evaluation of T
Cell Subsets in B-CLL. UCLA Molecular Biology Symposium Chronic
Lymphocytic Leukemia: Recent Progress-Future Directions. R.
Galeand K. Rai (eds) Alan R. Liss, New York, 59, 1987.
Fudenberg, H.H, Whitten,
H.D., Galbraith, G.M.P., Goust, J.M., Patrick, C.W. and Keller,
R.H.: Deficiency of 'Interactive' T Cells in Individuals with
Recurrent Infection: Effect of DLE-TF Therapy. Am J Med. In Press,
1994.
Keller, R.H., Van Reil,
F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G. and
Fletcher, M.A.: Association of Histocompatability Class II
Antigens with the Chronic Fatigue Immune Dysfunction Syndrome. In
Clin Inf Disease 1 8(Supp 1): S154-156, 1994.
Papers Submitted, In
review and/or Revision
Patrick, C.W. and
Keller, R.H.: A Comparative Study of Anticoagulants in Cell
Surface Maker Phenotyping and Functional Analysis. Am J Clin
Pathol.
Keller, R.H., Choi, H.,
Libnoch, J.A. and Patrick, C.W.: A Natural Murine Model of
Non-Hodgkin's Lymphoma. J Immunol (in revision).
Choi, H., Libnoch, J.A.,
Aimargo, U., Heckman, M. and Keller, R.H.: Castelman's Tumor: Well
Differentiated Lymphocytic Lymphoma and Large Cell Lymphoma in a
Single Patient. Human Pathol (in revision).
Keller R.H., Wen K., and
Kirchenbaum G. ALL-ergese a TCM blend of standardized herbs for
the treatment of allergies. (in revision)
Adult Growth Hormone
Deficiency: A Correlate of Immune Overactivity (in preparation)
ABSTRACTS:
Asterisks (*) denote those papers selected for presentation at
national or international meetings.
* Keller, R.H.,
Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha- fetoprotein
in Human Lymphoproliferative Disease. Blood 46(4):1035, 1975.
* Guebel, A.P., Keller,
R.H., Summerskill, W.H.J., Tomasi, T.B. and Shorter, R.G.:
Cytotoxicity of Autologous and Normal Lymphocytes Against Isolated
Liver Cells in Patients with Primary Biliary Cirrhosis.
Gastroenterol 68:104, 1975.
* Keller, R.H.,
Summerskill, W.H.J., Guebel, A.P., Shorter, R.G., and Tomasi, T.B.:
Alpha-fetoprotein and Suppression of Cell Mediated Immunity in
Chronic Acute Liver Disease (CALD). Gastroenterol 70:A-43:901,
1976.
* Keller, R.H, Guirgis,
H., Lynch, H. and Tomasi, T.B.: Alpha-fetoprotein (AFP) in Cancer
Prone Families. Clin Res 24:331, 1976.
* Keller, R.H., Burritt,
M.F., Thompson, R.L. and Tomasi, T.B.: Alpha- fetoprotein (AFP):
Synthesis in Allogeneic Reactions. Clin Res 24:447, 1976.
* Keller, R.H., Burritt,
M.F. and Tomasi, T.B.: Alpha-fetoprotein (AFP) Synthesis in
Allogeneic Reactions. Eleventh Leukocyte Culture Conference,
Tucson, AZ, September 1976.
* Guirgis, H.A., Lynch,
H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J., Lynch, J.,
Rankin, L., Maoney, K. and Harris, R.: Carcinoembryonic Antigen (CEA)
and Alpha-fetoprotein (AFP) in Cancer Prone Families. In
Proceedings of the Scientific Session of the Third International
Symposium on the Detection and Prevention, 1976.
* Vogten, A.J.M.,
Shorter, R.G., Summerskill, W.M.J., Keller, R.H. and Tomasi, T.B.:
Cell Mediated Cytotoxicity Against Human Liver Lipoprotein in
Liver Disease. Gastroenterol 71:A-41:934, 1976.
* Keller, R.H. and
Tomasi, T.B.: AFP: A Potential Regulator of Immune Function.
Second International Conference on Disease of the Liver. Bethesda,
MA, March 1977.
Keller, R.H., Blake, D.G.,
Lyman, S., Libnoch, J.A. and Fabiance, M.: Suppressor Cells in
Asymptomatic Chronic Lymphocytic Leukemia. Clin Res 27:298, 1979.
Keller, R.H., Blake, D.G.,
Lyman, S. and Siebenlist, R.: Altered Immunoregulation in Chronic
Lymphocytic Leukemia. Blood 54:97A, 1979.
Blake, D.G., Libnoch,
J.A., Lyman, S. and Keller, R.H.: Altered Immunologic Reactivity
in Myelodysplastic Disorders. Blood, 54:97A, 1979.
* Miller, P.P, Jordan,
R.E. and Keller, R.H.: Suppression of Human Lymphocyte Response by
Circulating Immune Complexes. Clin Res 28: 351, 1980.
* Keller, R.H., Fink,
N.J., Lyman, S. and Pederson, G.: Altered Immunoregulation in
Hypersensitivity Pneumonitis. Clin Res 28:102, 1980.
* Keller, R.H., Lyman,
S. and Siebenlist, R.: The Influence of Human Mononuclear Cell
Histamine Production on T Cell Immunoregulation. Clin Res 28:230,
1980.
* Keller, R.H., Lyman,
S. and Siebenlist, R.: Histamine in the Immune Response. 4th World
Congress of Immunology, Paris, France. July 1980.
* Kaplan, H.J., Asberg,
T.M. and Keller, R.H.: Lymphocyte Subset in Clinical Uveitis. Abs
Assoc Res Vision Opthal p. 33, 1980.
* Siebenlist, R.,
Calvanico, N.J., Stevens, J.O. and Keller, R.H.: Immunoregulation
in Hypersensitivity Pneumonitis. Fourth Midwest Autumn Immunology
Conference, Chicago, IL, 1980.
* Lyman, S., Patrick,
C.W. and Keller, R.H.: Non-Hodgkin's Lymphoma in the Mouse: A
Naturally Occurring Murine Model of NHL. Fourth Midwest Autumn
Immunology Conference, Chicago, IL, 1980.
* Young, D.G., Hussey,
C.V., Keller, R.H. and Pisciotta, A.V.: Eradication of Acquired
Factor VII Inhibitor in Hodgkin's Disease Following Chemotherapy.
Am Fed Clin Res 28(4):731, 1980.
* Keller, R.H., Patrick,
C.W., Swartz, S.J., Libnoch, J.A. and Jordan, R.E.: FlowCytometry
as an Adjunct in the Diagnosis and Staging of Lymphoproliferative
Disease. IX International Conference on Analytical Cytology.
Schloss Elmau, Germany, 1980.
* Wilson, R.J., Greiff,
D. and Keller, R.H.: Cryopreservation of Non- specific T Cell
Suppressor Cells. Cryobiol 17:597, 1980.
* Pontzer, C. and
Keller, R.H.: Rabbit Peripheral Blood T Cell Separation. Fed Am
Soc Exp Biol, 1980.
* Keller, R.H.,
Calvanico, N.J. and Stevens, J.O.: Immunoregulation in Pigeon
Breeders Disease. Clin Res 29:370, 1981.
* Keller, R.H.,
Kirchner, P., Lyman, S., Siebenlist, R., Choi, H. and Patrick, C.W.:
Immunoregulatory T Cells in Non-Hodgkin's Lymphomas. Blood 58:313,
1981.
* Keller, R.H., Lyman,
S., Choi, H. and Patrick, C.W.: A Natural Model of Non-Hodgkin's
Lymphoma. Blood 58:524, 1981.
* Lauer, S., Casper, J.,
Keller, R.H., Kirchner, P. and Camitta, B.: The Use of Counterflow
Centrifugation-Elutriation for the Separation of Bone Marrow
Lymphoid Cells in Children with Acute Lymphocytic Leukemia (ALL)
and Metastatic Solid Tumors. Blood 58:133, 1981.
* Keller, R.H., Choi, H.
and Patrick, C.W.: Nodular Non-Hodgkin's Lymphoma in the Mouse.
Blood 60:114A, 1982.
* Keller, R.H., Lyons,
M., Troy, J. and Jordan, R.E.: Peripheral Blood Aneuploidy in
Mycosis Fungoides and Pre-mycotic Lesions. Blood 60:146A, 1982.
* Keller, R.H., Swartz,
S.J., Lyons, M., Troy, J. and Jordan, R.E.: Peripheral Blood
Involvement in Skin-limited T Cell Malignancy. Am Fed Clin Res
31:568, 1983.
* Geoghegan, W.D.,
Jordan, R.E. and Keller, R.H.: Non-Langerhans Cells in the
Keratinocyte Band in Culture Expressing HLA-DR. Invest Derm Am Fed
Clin Res 31:568, 1983.
* Keller, R.H., Swartz,
S.J., Patrick, C.W. and Kaplan, H.J.: Intraocular Lymphoma: A
Possible Systemic Disease. Am Fed Clin Res 31:315, 1983.
* Patrick, C.W., Libnoch,
J.A., Choi, H. and Keller, R.H.: Flow Cytometric Peripheral Blood
Cell Surface Analysis as a Predictor of Richter's Syndrome (RS) in
Chronic Lymphocytic Leukemia. Blood 62:756, 1983.
* Patrick, C.W., Swartz,
S.J. and Keller, R.H.: A Comparative Study of Heparin and
Potassium EDTA as Anticoagulants for Cell Surface Marker and
Immunologic Functional Analysis. Am J Clin Pathol, 1983.
* Keller, R.H., Swartz,
S.J., Patrick, C.W., Steven, G. and Torke, N.J.: Regression of
Natural Murine Non-Hodgkin's Lymphoma Following Immunotherapy with
Immunoregulatory Cell Types. Blood 62:756, 1983.
* Keller, R.H., Wagner,
D. and Patrick, C.W.: Sequential T Cell Phenotypic and Functional
Changes During a Comparative Study of Rhinovirus Infection in
Patients with the Acquired Immune Deficiency Syndrome (AIDS).
Blood 62:352, 1983.
* Keller, R.H., Swartz,
S.J. and Patrick, C.W.: Metachromatic Granules in Human T8 (CD8)
Bearing Lymphocytes. Fifth World Congress of Immunology. Tokyo,
Japan. July 1983.
Libnoch, J.A., Patrick,
C.W., Griffin, J. and Keller, R.H.: Flow Cytometric Cell Surface
Analysis as a Predictor of Leukemic Transformation in the
Myeo-dyplastic Syndrome (MDS). Blood 62:610A, 1983.
* Calvanico, N.J.,
Pontzer, C. and Keller, R.H.: Regulation of Aerosol Induced
Pulmonary Inflammation in Rabbits. XII Congress of the European
Academy of Allergy and Clinical Immunology, Rome, Italy, 1983.
* Patrick, C.W., Swartz,
S.J., McFadden, P.W., Wallace, A. and Keller, R.H.: A Comparative
Study of Manual and Flow Cytometry Cell Surface Marker Analysis.
Soc Analytical Cytology, Sea Island, Georgia, 1983.
* Keller, R.H., Swartz,
S.J., Troy, J., Patrick, C.W. and Jordan, R.E.: Peripheral Blood
Involvement in Skin Limited T Cell Malignancy. Soc Analytical
Cytology, Sea Island, Georgia, 1983.
* Keller, R.H., Swartz,
S.J., Leven, S. and Bar Sella, S.: Immunoregulation in
Hypersensitivity Pneumonitis: Phenotypic and Functional Studies of
Bronchoalveolar Lavage Lymphocytes. Am Acd Allergy 130:766-771, \
1984.
* Keller, R.H., Swartz,
S.J., McFadden, P.W., Milson, T.J., Hermann, J., Thomas, E. and
Patrick, C.W.: Abnormal Peripheral Blood T Cell DNA Content in
Skin Limited T Cell Malignancy. Second International Conference on
Malignant Lymphoma, Lugano, Switzerland, June 1984.
* Patrick, C.W.,
Harrison, K.A, Libnoch, J.A., Cozine, M.G. and Keller, R.H.:
Monoclonal Antibody Profiles in Human B Cell Lymphoproliferative
Disorders Suggests that B4 Positive Lymphocytes which Lack
Expression of B1 Antigen May Include the B Memory Cells. Second
International Conference on Malignant Lymphoma, Lugano,
Switzerland, June 1984.
* Patrick, C.W.,
McFadden, P.W., Buchholz, T.B., Milson, T.J., Libnoch, J.A. and
Keller, R.H.: The Non-relevance of T4 to T8 (CD4:CD8) Ratios to
Disease Activity in B Cell Malignancies. Second International
Conference on Malignant Lymphoma, Lugano, Switzerland, June 1984.
* Keller, R.H., Swartz,
S.J., Patrick, C.W., Steven, G. and Torke, N.J.: Treatment of
Naturally Occurring Murine Non-Hodgkin's Lymphomas Using
Immunoregulatory Cell Types and IL-2. Second International
Conference Malignant Lymphoma, Lugano, Switzerland, June 1984.
* Kissebah, A.H., James,
R. Krakower, G., Arnaud, C., Etienne, J. and Keller, R.H.: Holding
Media for Cell Surface Phenotypic Analysis. Midwest Autumn
Conference, Chicago, IL, November 1984.
* Milson, T.J., Patrick,
C.W., Torke, N.J., Janicek, K.M., Harrison, K.A. and Keller, R.H.:
Alterations in Lymphoid and Myeloid Cell Surface Marker Phenotype
Profiles Associated with the Development of Basophilic Crisis in
Chronic Granulocytic Leukemia (Ph + CGL). Blood 64(5):195A, 1984
* Patrick, C.W., Libnoch,
J.A., Milson, T.J., Kortright, K.H. and Keller, R.H.: Common
Variant of B Cell Chronic Lymphocytic Leukemia is Defined by the
Monoclonal Antibody TQ1 (Leu 8). Blood 65(5):149, 1984.
* Baumann, M.A.,
Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Myeloid and
Lymphoid Cell Surface Phenotype in Myelodysplasia: Correlation
with In Vitro Assessment of Immune Function. Blood 64(5):186A,
1984.
* Keller, R.H., Larrick,
J.W., Swartz, S.J., Torke, N.J. and Patrick, C.W.: Treatment of a
Natural Model of Murine Non-Hodgkin's Lymphoma with Recombination
Interleukin 2(IL-2). Blood 64(5):181, 1984.
* Steven, G.C., Choi,
H., Heckman, M.G. and Keller, R.H.: Comparison of Flow Cytometry
and In sit Cell Surface Marker Analysis. Midwest Student Research
Forum XVI, Wright State University, February 1985.
* Kissebah, A.H.,
Krakower, G., James, R., Aranaud, C., Etienne, J. and Keller, R.H.:
Regional Differences in Preadiopocyte Growth Potential from
Immature and Sexually Mature Female Rats. Am Fed Clin Res 33:434,
1985.
* Kissebah, A.H.,
Krakower, G., James, R., Aranaud, C., Etienne, J. and Keller, R.H.:
Regional Specialization of Subcutaneous Tissue Growth Potential:
Relationship to Ovarian Function. Am Diabetes Assoc, Toronto,
Canada, November 1985.
* Baumann, M.A., Milson,
T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Correlation
of Natural Killer Cell Count with Prognosis in Large Cell
Lymphoma. Blood 66:185, 1985.
* Patrick, C.W., Libnoch,
J.A. and Keller, R.H.: Clinical Utility of Dual Immunofluorescence
Assay of Monoclonal Antibodies TQ1 and (CD19) on Peripheral Blood
Cells in Chronic Lymphocytic Leukemia. Blood 66: 181, 1985.
* Patrick, C.W., Libnoch,
J.A., Baumann, M.A. and Keller, R.H.: Alterations of Myeloid
Surface Receptors recognized by the Monoclonal Antibody MY 9
(CD33) in the Peripheral Blood May Serve to Identify Those
Myelodysplastic Patients at Increased Risk for Leukemic
Conversion. Blood 66:226, 1985.
Keller, R.H., Milson,
T.J., McFadden, P.W. and Patrick, C.W.: In Vitro Augmentation of
Immunologic Responsiveness in Patients with AIDS and ARC Using
Isoprinosine. Blood 66:113, 1985.
Keller, R.H., Patrick,
L.C. and Patrick, C.W.: Isoprinosine Augments In \ Vitro
Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia. Blood
66:202, 1985.
* Keller, R.H., Patrick,
L.C. and Patrick, C.W.: Isoprinosine Augments In Vitro
Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia (B-CLL).
International Symposium on Recent Approaches to Chronic
Lymphoproliferative Disease, Prague, Czechoslovakia, September
1985.
* Keller, R.H., Milson,
T.J. and Patrick, C.W.: The Relationship of Larger Lymphoid
Elements, Clonally Restricted DNA Cell Cycle Analysis and Rai
Staging in Chronic Lymphocytic Leukemia (B-CLL). International
Symposium on Recent Approaches to Chronic Lymphoproliferative
Disease, Prague, Czechoslovakia, September 1985.
* Patrick, C.W., Libnoch,
J.A. and Keller, R.H.: Immunophenotypic Dissection Of Chronic
Lymphocytic Leukemia. International Symposium on Recent Approaches
to Chronic Lymphoproliferative Disease, Prague, Czechoslovakia,
September 1985.
* Keller, R.H., Libnoch,
J.A., Patrick, L.C. and Patrick, C.W.: In Vitro Improvement of
Cellular and Humoral Immune Response by Isoprinosine in B-CLL. XXI
Congress of the International Society of Haematology, Sydney,
Australia, May 1986.
* Patrick, C.W., Libnoch,
J.A. and Keller, R.H.: Prolymphocytic Leukemia of B Cells is a
Distinct Biologic Stage in B Cell Maturation. XXI Congress of The
International Society of Haematology, Sydney, Australia, May 1986.
* Patrick, C.W., Libnoch,
J.A. and Keller, R.H.: Sequential Changes in the Expression of
Lymphoid Surface Membrane Receptors in Chronic B Cell
Lymphoproliferative Disease. XXI Congress of the International
Society of Haematology, Sydney, Australia, May 1986.
* Patrick, C.W., Libnoch,
J.A. and Keller, R.H.: Clinical Utility of Dual Immunofluorescence
Assay of Monoclonal Antibodies TQ1 and B4 (CD19) on Circulating B
Cells in Chronic Lymphocytic Leukemia (B-CLL). Sixth International
Congress of Immunology, Toronto, Canada, July 1986.
* Keller, R.H., Milson,
T.J., Ellingboe, K.M. and Patrick, C.W.: Sequential Clinical,
Immunoregulatory, Phenotypic and Functional Changes in Patients
with AIDS and ARC treated with Isoprinosine. XXI Congress of the
International Society of Haematology, Sydney, Australia, May 1986.
* Keller, R.H., Milson,
T.J., Ellingboe, K.M. and Patrick, C.W.: Sequential Clinical,
Immunoregulatory, Phenotypic and Functional Changes in Patients
with AIDS and ARC treated with Isoprinosine. International
Conference on the Acquired Immunodeficiency Syndrome, Paris,
France, June 1986.
* Keller, R.H., Libnoch,
J.A. and Patrick, C.W.: T Cell Alterations in B-CLL: Sequential
Changes in CD4 and CD8 Bearing Cells and in T Cell
Immunoregulation. UCLA Symposium on Molecular and Cell Biology,
Silverado, California, December 1986.
* Patrick, C.W., Libnoch,
J.A., Kallas, G.A. and Keller, R.H.: Sequential Immunophenotypic
Studies in Chronic Lymphocytic Leukemia. UCLA Symposium on
Molecular and Cell Biology, Silverado, California, December 1986.
* Reiter, W.M., Berger,
D.S., Vorce, S., Cimoch, P.J., Vargas, A. and Keller, R.H.:
Combination Zidovudine and Didanosine Therapy for Patients
Remaining Persistently HIV P24 Antigen-Positive Despite Zidovudine
Monotherapy. VIII International AIDS Conference, Amsterdam,
Netherlands, 1992.
* Reiter, W.M., Keller,
R.H., Cimoch, P.J. and Forgione, A.: A Rapid Quantitative Flow
Cytometry Assay to Evaluate CD4 + - Lymphocyte Activation
Potential in Patients with HIV-1 Infection. VIII International
AIDS Conference, Amsterdam, Netherlands, 1992.
* Cimoch, P.J., Reiter,
W.M., Vorce, D., Cassarella, S.K., Thompson, B. and Keller, R.H.:
The Occurrence of Cytomegalovirus (CMV) Viruria in Late- Stage
HIV-1 Infection and its Association with CMV Organ Involvement.
VIII International AIDS Conference, Amsterdam, Netherlands, 1992.
* Reiter, W.M., Beach,
R.S., Vorce, D., Cimoch, P.J., Vargas, A., Thompson, B. and
Keller, R.H.: Longitudinal Analysis the Effect of Anti-retroviral
Monotherapy on CD4+ Lymphocyte Percentage. VIII International AIDS
Conference, Amsterdam, Netherlands, 1992.
* Keller, R.H., Van Reil,
F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G. and
Fletcher, M.A.: Correlation of DR4 and DQ1 with Immunologic
Defects in the Chronic Fatigue Syndrome. First International
Chronic Fatigue Syndrome Research Conference, Albany, New York,
October 1992.
* Keller, R.H., Reiter,
W.M., Lane, J.T., Klimas, N.G., Vargas, A. and Maislis, J.A.:
Treatment of Late-Stage AIDS Patients with Combined Monthly
Anti-HIV Hyperimmunoglobulins and Haplotype-matched Peripheral
Blood Lymphocytes. XI International Conference on AIDS, Berlin,
1993.
Reiter, W.M., Cimoch,
P.J., Vorce, D.E., Keller, R.H., Berger, D. and Ping, A.:Eighteen
Month Longitudinal Analysis of the Effect of Zidovine
MonotherapyCompared to Combination Antiretroviral Therapy on HIV1
Disease Progression. IX International Conference on AIDS, Berlin
1993.
* Reiter, W.M., Vorce,
D.E., Cimoch, P.J., Keller, R.H., Berger, D.S., and Ping, A.C.:
Cytotoxic CD8+ Lymphocyte Response to HIV-1 Infection Correlated
with Longitudinal Analysis of CD4+ Lymphocyte Percentage. IX
International Conference on AIDS, Berlin, 1993
Berger, D.S., Reiter,
W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H. and Ping, A.C.:
Prevalence of Red Blood Cell Magnesium Deficiency in HIV-1
Infected Patients and its Association with Fatigue and Myalgia. IX
International Conference on AIDS, Berlin, 1993.
Reiter, W.M., Tomaka,
F., Keller, R.H., Cimoch, P.J., Vargas, A. and Vorce, D.E.:
Unrecognized Moderate to Advanced Immunodeficiency in "HIV-Aware"
Asymptomatic, Untreated Person with HIV-1 Infection. IX
International Conference on AIDS, Berlin, 1993.
* Gomatos, P.J., Keller,
R.H., Reiter, W.M., Lane, J.T., Cimoch, P.J., Vorce, D.E.,
Gianetti, B.L. and Uribe, M.R.: Haplotype-Matched Peripheral Blood
Mononuclear Cell (PBMC) Transfusions in Patients with Late-Stage
AIDS. X International Conference on AIDS, Yokohama, Japan, 1994.
* Cimoch, P.J., Loss,
S.D., Houghton, R.A., Reiter, W.M., Keller, R.H., Vorce, D.E.,
Nemecheck, P.M., Berger, D.S. and Tomaka, F.L.: Antibody Response
to Pneumococcal Vaccination in HIV-1 Infected Patients. X
International Conference on AIDS, Yokohama, Japan, 1994.
* Tomaka, F.L., Cimoch,
P.J., Reiter, W.M., Keller, R.H., Berger, D.S., Piperato, J.R.,
Nemecheck, P.M., Loss, S.D. and Houghton, R.A.: Prevalence of
Nutritional Deficiencies in Patients with HIV-1 Infection. X
International Conference on AIDS, Yokohama, Japan, 1994.
* Keller, R.H., Helder,
L.M., Piperato, J.P., Klimas, N.G., Reiter, W.M., Fletcher, M.A.,
Vorce, D.E. and Pittibone, H.: Symptomatic Improvement Associated
with Down Regulation of Immune Hyper Reactivity by Calcium Channel
Blockade in CFIDs. American Association for Chronic Fatigue
Syndrome Research Conference, Ft Lauderdale, Florida, 1994.
* Keller, R.H., Nolan,
R.P. and Patrick, L.C.: Natural Human Interferon ( (Alpha
Leukoferon) Therapy in a Cohort of Hemophiliacs Co-infected with .
HIV and Hepatitis C. Fourth Conference on Retroviruses and
Opportunistic Infections,Washington, DC, 1997.
* Patrick, C.W. and
Keller, R.H.: Patient Screening for Myelodysplasia in Long- Term
HIV+ Individuals. Conference on Clinical Laboratory Testing in
HIV, Atlanta, GA, 1998.
* Patrick, C.W., DeLeon,
M., A. Leon, and Keller, R.H.: Measurement of glutathione (GSH) as
Indicator of Immune Status. Conference on Clinical Laboratory
Testing in HIV, Atlanta, GA 1998.
** Kushch, A. and
Keller, R.H.: Neuropsychological Correlates of Adjunct Therapy
with a Nutritional/Vitamin Supplement in a Medical Patient Sample.
National Academy of Neuropsychology, ** Orlando, FL, November
2000.
Keller, R.H.:PBS 119
Abstract "Clinical Results of PBS 119 in Eight Patients for Two
Years" Submitted to the 12th Conference on Retroviruses &
Opportunistic Infections (CROI), 2005
Keller, R.H.: PBS 119
Abstract "In Vitro Analysis of PBS 119 Against HIV Viral Activity
in Lab Adapted and HAART Resistant Strains of HIV" Submitted to
the 12th Conference on Retroviruses & Opportunistic Infections (CROI),
2005
* Keller, R.H, Miller D
glutathione and DHA deficiency in HIV/AIDS : Correction with
Immune Vitality 16th International AIDS congress Toronto Canada
8/2006
* Keller, R.H And Nyugen
V. : PBS 119 A Novel Host - Viral Interaction inhibitor 16th
International AIDS Congress Toronto Canada 8/2006
Dr. Keller has served on the
faculties of the Mayo Graduate School of Medicine, the University of
Wisconsin and the Medical College of Wisconsin (Marquette Univ.) He has
published more than 100 original articles in various scientific and
medical journals and has been awarded several patents. Dr Keller was
elected to The Board of Governors of the American Academy of HIV
medicine, and serves on the Scientific Advisory Board of several Biotech
companies. The Consumers Research Council has named Dr. Keller one of
America's Top Physicians in 2003, 2004 and 2005 in the fields of
Internal Medicine, Immunology and Hematology. Dr. Keller continues his
medical practice and research activities at his clinic and laboratory in
Florida and is Chairman of the Board and Chief Scientific Officer of
Phoenix Biosciences, Inc.
*Testimonies
